Literature DB >> 26069261

Predictive Factors for Rebleeding After Aneurysmal Subarachnoid Hemorrhage: Rebleeding Aneurysmal Subarachnoid Hemorrhage Study.

Carlina E van Donkelaar1, Nicolaas A Bakker2, Nic J G M Veeger2, Maarten Uyttenboogaart2, Jan D M Metzemaekers2, Gert-Jan Luijckx2, Rob J M Groen2, J Marc C van Dijk2.   

Abstract

BACKGROUND AND
PURPOSE: Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating type of stroke associated with high morbidity and mortality. One of the most feared complications is an early rebleeding before aneurysm repair. Predictors for such an often fatal rebleeding are largely unknown. We therefore aimed to determine predictors for an early rebleeding after aSAH in relation with time after ictus.
METHODS: This observational prospective cohort study included all consecutive patients admitted with aSAH between January 1998 and December 2014 (n=1337) at our University Neurovascular Center. Clinical predictors for rebleeding ≤24 hours were identified using multivariable Cox regression analyses. Kaplan-Meier analyses were applied to evaluate the time of rebleeding ≤72 hours after aSAH.
RESULTS: A modified Fisher grade of 3 to 4 was a predictor for an in-hospital rebleeding ≤24 hours after ictus (adjusted hazard ratio, 4.4; 95% confidence interval, 2.1-10.6; P<0.001). The numbers needed to treat to prevent 1 rebleeding ≤24 hours was calculated 15 (95% confidence interval, 10-25). Also, the initiation of external cerebrospinal fluid-drainage (adjusted hazard ratio, 1.9; 95% confidence interval, 1.4-2.5; P<0.001) was independently associated with a rebleeding ≤24 hours. Cumulative in-hospital rebleeding rates were 5.8% ≤24 hours, and 1.2% in the time frame 24-72 hours after ictus.
CONCLUSIONS: In our opinion, timing of treatment of aSAH patients, especially those with an modified Fisher grade of 3 or 4 in a good clinical condition, should be reconsidered. These aSAH patients might be regarded a medical emergency, requiring aneurysm repair as soon as possible. In this respect, our findings should provoke the debate on timing of aneurysm repair, especially in patients considered to be at high risk for rebleeding.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  aneurysm; rebleeding; regression analysis; stroke; subarachnoid hemorrhage

Mesh:

Year:  2015        PMID: 26069261     DOI: 10.1161/STROKEAHA.115.010037

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  21 in total

1.  [Intensive care studies from 2015/2016].

Authors:  C J Reuß; M Bernhard; C Beynon; S Hofer; C Jungk; D Michalski; M A Weigand; T Brenner
Journal:  Anaesthesist       Date:  2016-07       Impact factor: 1.041

2.  MRI Characterization in the Acute Phase of Experimental Subarachnoid Hemorrhage.

Authors:  Dewei Guo; D Andrew Wilkinson; B Gregory Thompson; Aditya S Pandey; Richard F Keep; Guohua Xi; Ya Hua
Journal:  Transl Stroke Res       Date:  2016-11-28       Impact factor: 6.829

Review 3.  Acute rerupture after coil embolization of ruptured intracranial saccular aneurysms: A literature review.

Authors:  Kailing Li; Yunbao Guo; Ying Zhao; Baofeng Xu; Kan Xu; Jinlu Yu
Journal:  Interv Neuroradiol       Date:  2017-12-12       Impact factor: 1.610

4.  A Modified Method for Creating Elastase-Induced Aneurysms by Ligation of Common Carotid Arteries in Rabbits and Its Effect on Surrounding Arteries.

Authors:  Daraspreet Kainth; Pascal Salazar; Cyrus Safinia; Ricky Chow; Ornina Bachour; Sasan Andalib; Alexander M McKinney; Afshin A Divani
Journal:  J Vasc Interv Neurol       Date:  2017-01

5.  Pharmaceutical Management for Subarachnoid Hemorrhage.

Authors:  Arnav Barpujari; Chhaya Patel; Rebecca Zelmonovich; Alec Clark; Devan Patel; Kevin Pierre; Kyle Scott; Brandon Lucke Wold
Journal:  Recent Trends Pharm Sci Res       Date:  2021

6.  Desmopressin administration and rebleeding in subarachnoid hemorrhage: analysis of an observational prospective database.

Authors:  Charles L Francoeur; David Roh; J Michael Schmidt; Stephan A Mayer; M Cristina Falo; Sachin Agarwal; E Sander Connolly; Jan Claassen; Mitchell S V Elkind; Soojin Park
Journal:  J Neurosurg       Date:  2018-01-01       Impact factor: 5.115

7.  Treatment at Safety-Net Hospitals Is Associated with Delays in Coil Embolization in Patients with Subarachnoid Hemorrhage.

Authors:  Daniel A Donoho; Arati Patel; Ian A Buchanan; Frances Chow; Li Ding; Arun P Amar; Frank Attenello; William J Mack
Journal:  World Neurosurg       Date:  2018-09-08       Impact factor: 2.104

8.  Timing of treatment of aneurysmal subarachnoid haemorrhage: are the goals set in international guidelines achievable?

Authors:  Abdurehman Choudhry; Daniel Murray; Paula Corr; Deirdre Nolan; Deirdre Coffey; Stephen MacNally; Alan O'Hare; Sarah Power; Matthew Crockett; John Thornton; Daniel Rawluk; Paul Brennan; Mohsen Javadpour
Journal:  Ir J Med Sci       Date:  2021-02-18       Impact factor: 1.568

Review 9.  The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets.

Authors:  Rongrong Bai; Yue Lang; Jie Shao; Yu Deng; Reyisha Refuhati; Li Cui
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 4.146

Review 10.  The Role of the Blood Neutrophil-to-Lymphocyte Ratio in Aneurysmal Subarachnoid Hemorrhage.

Authors:  Lingxin Cai; Hanhai Zeng; Xiaoxiao Tan; Xinyan Wu; Cong Qian; Gao Chen
Journal:  Front Neurol       Date:  2021-06-03       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.